Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 immunitor

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Bourinbaiar, Aldar S ^b   Metadilogkul, Orapun ^a   Jirathitikal, Vichai ^b  

^a RAJAVITHI HOSPITAL   (Thailand)

^b Immunitor USA Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERFERON; UNCLASSIFIED DRUG; V 1 IMMUNITOR; ZIDOVUDINE; V-1 IMMUNITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS PATIENT; ALLOIMMUNITY; ARTICLE; CHILD; CHINESE HERB; DIAGNOSTIC ACCURACY; DRUG WITHDRAWAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCHOOL CHILD; SEROCONVERSION; THAILAND; TREATMENT DURATION; VIRUS LOAD; BLOOD; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY; RETROSPECTIVE STUDY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS VACCINES; CHILD; CHILD, PRESCHOOL; FEMALE; HIV ANTIBODIES; HIV-1; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THAILAND; VIRAL LOAD; YOUNG ADULT;

EID: 58949097902     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/934579     Document Type: Article

References (53)

1. Bartlett J. G., Gallan J. E., Medical Management of HIV 2003 Baltimore, Md, USA Johns Hopkins University Chapter II, HIV Serology
2. MacDonald K. L., Jackson J. B., Bowman R. J., Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications Annals of Internal Medicine 1989 110 8 617 621
3. Nakamura R. M., Bylund D. J., Rooney K. E., Current status of clinical laboratory tests for the human immunodeficiency virus Journal of Clinical Laboratory Analysis 1990 4 4 295 306
4. Gschnait F., Schmidt B. L., Schwarz T., Heinz F. X., Kunz C., HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests Wiener Klinische Wochenschrift 1987 99 15 536 539
5. Montagnier L., Brenner C., Chamaret S., Human immunodeficiency virus infection and AIDS in a person with negative serology The Journal of Infectious Diseases 1997 175 4 955 959
6. Quíonez J. M., Begue R. E., Steele R. W., HIV seronegativity in an infant with the acquired immunodeficiency syndrome Southern Medical Journal 1998 91 9 879 881
7. Imagawa D. T., Lee M. H., Wolinsky S. M., Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods The New England Journal of Medicine 1989 320 22 1458 1462
8. Sullivan P. S., Schable C., Koch W., Persistently negative HIV-1 antibody enzyme immunoassay screening results for patients with HIV-1 infection and AIDS: serologic, clinical, and virologic results AIDS 1999 13 1 89 96
9. Reimer L., Mottice S., Schable C., Absence of detectable antibody in a patient infected with human immunodeficiency virus Clinical Infectious Diseases 1997 25 1 98 100
10. Ellenberger D. L., Sullivan P. S., Dorn J., Viral and immunologic examination of human immunodeficiency virus type 1-infected, persistently seronegative persons The Journal of Infectious Diseases 1999 180 4 1033 1042
11. Root-Bernstein R. S., Five myths about AIDS that have misdirected research and treatment Genetica 1995 95 13 111 132
12. Chantry C. J., Cooper E. R., Pelton S. I., Zorilla C., Hillyer G. V., Diaz C., Seroreversion in human immunodeficiency virus-exposed but uninfected infants Pediatric Infectious Disease Journal 1995 14 5 382 387
13. Bakshi S. S., Tetali S., Abrams E. J., Paul M. O., Pahwa S. G., Repeatedly positive human immunodeficiency virus type 1 DNA polymerase chain reaction in human immunodeficiency virus-exposed seroreverting infants Pediatric Infectious Disease Journal 1995 14 8 658 662
14. Gutierrez M., Soriano V., Bravo R., Vallejo A., Gonzalez-Lahoz J., Seroreversion in patients with end-stage HIV infection Vox Sanguinis 1994 67 2 238 239
15. Zaaijer H. L., Bloemer M. H., Lelie P. N., Temporary seronegativity in a human immunodeficiency virus type 1-infected man Journal of Medical Virology 1997 51 1 80 82
16. Perrin L. H., Zubler R., Hirschel B., Reversal of positive serology for human immunodeficiency virus (HIV). Apropos of 2 case reports Schweizerische Medizinische Wochenschrift 1988 118 45 1641 1644
17. Farzadegan H., Polis M. A., Wolinsky S. M., Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study Annals of Internal Medicine 1988 108 6 785 790
18. Coyne K. M., Parry J. V., Atkins M., Pozniak A., McOwan A., Spontaneous HIV-1 seroreversion in an adult male Sexually Transmitted Diseases 2007 34 9 627 630
19. Koech D. K., Obel A. O., Efficacy of Kemron (low dose oral natural human interferon alpha) in the management of HIV-1 infection and acquired immune deficiency syndrome (AIDS) East African Medical Journal 1990 67 7, supplement 2 SS64 SS70
20. Lu W. B., Wen R. X., Guan C. F., A report on 8 seronegative converted HIV/AIDS patients with traditional Chinese medicine Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 1997 17 5 271 273
21. Jurriaans S., Sankatsing S. U. C., Prins J. M., HIV-1 seroreversion in an HIV-1-seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenoiate mofetil AIDS 2004 18 11 1607 1608
22. Kassutto S., Johnston M. N., Rosenberg E. S., Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy Clinical Infectious Diseases 2005 40 6 868 873
23. Abalaka J. O. A., Attempts to cure and prevent HIV/AIDS in central Nigeria between 1997 and 2002: opening a way to a vaccine-based solution to the problem? Vaccine 2004 22 29-30 3819 3828
24. Ngu V. A., Ambe F., Effective vaccines against and immunotherapy of the HIV: a preliminary report (1) Journal of the Cameroon Academy of Sciences 2001 1 2 8
25. Jirathitikal V., Bourinbaiar A. S., Preclinical and safety studies of V-1 Immunitor International Journal of Biotechnology 2007 9 3-4 318 331
26. Jirathitikal V., Metadilogkul O., Bourinbaiar A. S., Increased body weight and improved quality of life in AIDS patients following V-1 Immunitor admimnistration European Journal of Clinical Nutrition 2004 58 1 110 115
27. Jirathitikal V., Bourinbaiar A. S., Effect of an oral therapeutic HIV-1 vaccine on aids patients with CD4 count above 250 cells/ mm3 Acta Virologica 2004 48 2 73 78
28. Jirathitikal V., Sooksathan P., Metadilogkul O., Bourinbaiar A. S., V-1 Immunitor: oral therapeutic AIDS vaccine with prophylactic potential Vaccine 2003 21 7-8 624 628
29. Bourinbaiar A. S., Jirathitikal V., Metadilogkul O., Phase II placebo-controlled study of V-1 Immunitor as a therapeutic modality for treatment of HIV Journal of Clinical Virology 2004 31 supplement 1 S55 S62
30. Metadilogkul O., Jirathitikal V., Bourinbaiar A. S., Prolonged survival of end-stage AIDS patients immunized with therapeutic HIV vaccine V-1 Immunitor Biomedicine & Pharmacotherapy 2005 59 8 469 473
31. Bourinbaiar A. S., Ajuang-Simbiri K., Simple procedure for estimating the efficiency of PCR Molecular Biotechnology 1996 6 1 87 89
32. Roy M. J., Damato J. J., Burke D. S., Absence of true seroreversion of HIV-1 antibody in seroreactive individuals Journal of the American Medical Association 1993 269 22 2876 2879
33. Metadilogkul O., Sribantao S., Buraparat S., Investigational Report on HIV-Positive Patients Who Became HIV-Negative (Report in Thai) 2002 Bangkok, Thailand Office of Occupational and Environmental Medicine, Ministry of Public Health and Occupational and Environmental Medicine Association of Thailand, Rajavithi General Hospital
34. Cummins L. M., Weinhold K. J., Matthews T. J., Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors Blood 1991 77 5 1111 1117
35. Koning F. A., van der Vorst T. J. K., Schuitemaker H., Low levels of human immunodeficiency virus type 1 DNA in high-risk seronegative men Journal of Virology 2005 79 10 6551 6553
36. Zagury D., Léonard R., Fouchard M., Immunization against AIDS in humans Nature 1987 326 6110 249 250
37. Bourinbaiar A. S., Root-Bernstein R. S., Abulafia-Lapid R., Therapeutic AIDS vaccines Current Pharmaceutical Design 2006 12 16 2017 2030
38. Stott E. J., Anti-cell antibody in macaques Nature 1991 353 6343 393
39. Arthur L. O., Bess J. W. Jr., Sowder R. C. II, Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines Science 1992 258 5090 1935 1938
40. Lopalco L., Pastori C., Cosma A., Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity AIDS Research and Human Retroviruses 2000 16 2 109 115
41. Spruth M., Stoiber H., Kacani L., Schönitzer D., Dierich M. P., Neutralization of HIV type 1 by alloimmune sera derived from polytransfused patients AIDS Research and Human Retroviruses 1999 15 6 533 543
42. Shearer G. M., Pinto L. A., Clerici M., Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS Immunology Today 1999 20 2 66 71
43. Bourinbaiar A. S., Abulafia-Lapid R., Autoimmunity, alloimmunization and immunotherapy of AIDS Autoimmunity Reviews 2005 4 6 403 409
44. Abulafia-Lapid R., Mayan S., Bentwich Z., T-cell vaccination against anti-CD4 autoimmunity in HIV-1 subtypes B and C-infected patientsan extended open trial Vaccine 2005 23 17-18 2149 2153
45. Page M., Ojugo A., Imami N., Hardy G., Gotch F., Almond N., Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccine AIDS 2007 21 3 375 377
46. Israeli E., Safadi R., Melhem A., Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial Liver International 2004 24 4 295 307
47. Batdelger D., Dandii D., Jirathitikal V., Bourinbaiar A. S., Open label trial of therapeutic hepatitis B vaccine V-5 Immunitor (V5) delivered by oral route Letters in Drug Design and Discovery 2007 4 8 540 544
48. Batdelger D., Dandii D., Jirathitikal V., Bourinbaiar A. S., Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C Vaccine 2008 26 22 2733 2737
49. Autran B., Murphy R. L., Costagliola D., Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452) AIDS 2008 22 11 1313 1322
50. Cornelissen M., Jurriaans S., Prins J. M., Bakker M., van der Kuyl A. C., Absence of seroreversion in 80 HAART-treated HIV-1 seropositive patients with at least five-years undetectable plasma HIV-1 viral load AIDS Research and Therapy 2006 3 1 3
51. Hare C. B., Pappalardo B. L., Busch M. P., Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection Clinical Infectious Diseases 2006 42 5 700 708
52. Tang J. W., Wong B. C. K., Lam E., Failure to confirm HIV infection in two end-stage HIV/AIDS patients using a popular commercial line immunoassay Journal of Medical Virology 2008 80 9 1515 1522
53. SUICIDE, Ministry to Probe Death of Medical Technician 2002 Bangkok, Thailand The Nation